Does severe hypoglycaemia influence microvascular complications in Type1 diabetes? An analysis of the Diabetes Control and Complications Trial database

E. S. Kilpatrick, A. S. Rigby, Stephen Atkin, B. M. Frier

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aims Severe hypoglycaemia may have a role in aggravating micro- and macrovascular disease in diabetes. Data from the Diabetes Control and Complication Trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with Type1 diabetes. Methods Using binary longitudinal multiple logistic regression, HbA1c at study baseline, mean HbA1c throughout the study and the number of severe hypoglycaemic episodes during the trial were compared to examine the risk of development/progression of retinopathy and nephropathy. Results Average HbA1c during the study and/or HbA1c at baseline were independently predictive of retinopathy and nephropathy both in the intensively and the conventionally treated patients (all P≤0.001). However, the number of hypoglycaemic episodes did not add to HbA1c in predicting retinopathy [odds ratio (95%CI) 0.99 (0.96-1.01), P=0.51 in intensively treated patients, 0.94 (0.89-1.00), P=0.05, conventional] or nephropathy [odds ratio (95%CI) 0.98 (0.95-1.01), P=0.48 intensive, 1.03 (0.98-1.10), P=0.17 conventional]. Conclusions The frequency of exposure to severe hypoglycaemia did not predict a different risk of developing retinopathy or nephropathy in either treatment group of the Diabetes Control and Complications Trial at any given HbA1c.

Original languageEnglish
Pages (from-to)1195-1198
Number of pages4
JournalDiabetic Medicine
Volume29
Issue number9
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Diabetes Complications
Hypoglycemia
Databases
Hypoglycemic Agents
Odds Ratio
Logistic Models
Control Groups
Therapeutics

Keywords

  • Glycated haemoglobin
  • Hypoglycaemia
  • Nephropathy
  • Retinopathy
  • Type1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Does severe hypoglycaemia influence microvascular complications in Type1 diabetes? An analysis of the Diabetes Control and Complications Trial database. / Kilpatrick, E. S.; Rigby, A. S.; Atkin, Stephen; Frier, B. M.

In: Diabetic Medicine, Vol. 29, No. 9, 09.2012, p. 1195-1198.

Research output: Contribution to journalArticle

@article{f3a9aefeba2f4a88a5c84ae5d36e5734,
title = "Does severe hypoglycaemia influence microvascular complications in Type1 diabetes? An analysis of the Diabetes Control and Complications Trial database",
abstract = "Aims Severe hypoglycaemia may have a role in aggravating micro- and macrovascular disease in diabetes. Data from the Diabetes Control and Complication Trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with Type1 diabetes. Methods Using binary longitudinal multiple logistic regression, HbA1c at study baseline, mean HbA1c throughout the study and the number of severe hypoglycaemic episodes during the trial were compared to examine the risk of development/progression of retinopathy and nephropathy. Results Average HbA1c during the study and/or HbA1c at baseline were independently predictive of retinopathy and nephropathy both in the intensively and the conventionally treated patients (all P≤0.001). However, the number of hypoglycaemic episodes did not add to HbA1c in predicting retinopathy [odds ratio (95{\%}CI) 0.99 (0.96-1.01), P=0.51 in intensively treated patients, 0.94 (0.89-1.00), P=0.05, conventional] or nephropathy [odds ratio (95{\%}CI) 0.98 (0.95-1.01), P=0.48 intensive, 1.03 (0.98-1.10), P=0.17 conventional]. Conclusions The frequency of exposure to severe hypoglycaemia did not predict a different risk of developing retinopathy or nephropathy in either treatment group of the Diabetes Control and Complications Trial at any given HbA1c.",
keywords = "Glycated haemoglobin, Hypoglycaemia, Nephropathy, Retinopathy, Type1 diabetes",
author = "Kilpatrick, {E. S.} and Rigby, {A. S.} and Stephen Atkin and Frier, {B. M.}",
year = "2012",
month = "9",
doi = "10.1111/j.1464-5491.2012.03612.x",
language = "English",
volume = "29",
pages = "1195--1198",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Does severe hypoglycaemia influence microvascular complications in Type1 diabetes? An analysis of the Diabetes Control and Complications Trial database

AU - Kilpatrick, E. S.

AU - Rigby, A. S.

AU - Atkin, Stephen

AU - Frier, B. M.

PY - 2012/9

Y1 - 2012/9

N2 - Aims Severe hypoglycaemia may have a role in aggravating micro- and macrovascular disease in diabetes. Data from the Diabetes Control and Complication Trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with Type1 diabetes. Methods Using binary longitudinal multiple logistic regression, HbA1c at study baseline, mean HbA1c throughout the study and the number of severe hypoglycaemic episodes during the trial were compared to examine the risk of development/progression of retinopathy and nephropathy. Results Average HbA1c during the study and/or HbA1c at baseline were independently predictive of retinopathy and nephropathy both in the intensively and the conventionally treated patients (all P≤0.001). However, the number of hypoglycaemic episodes did not add to HbA1c in predicting retinopathy [odds ratio (95%CI) 0.99 (0.96-1.01), P=0.51 in intensively treated patients, 0.94 (0.89-1.00), P=0.05, conventional] or nephropathy [odds ratio (95%CI) 0.98 (0.95-1.01), P=0.48 intensive, 1.03 (0.98-1.10), P=0.17 conventional]. Conclusions The frequency of exposure to severe hypoglycaemia did not predict a different risk of developing retinopathy or nephropathy in either treatment group of the Diabetes Control and Complications Trial at any given HbA1c.

AB - Aims Severe hypoglycaemia may have a role in aggravating micro- and macrovascular disease in diabetes. Data from the Diabetes Control and Complication Trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with Type1 diabetes. Methods Using binary longitudinal multiple logistic regression, HbA1c at study baseline, mean HbA1c throughout the study and the number of severe hypoglycaemic episodes during the trial were compared to examine the risk of development/progression of retinopathy and nephropathy. Results Average HbA1c during the study and/or HbA1c at baseline were independently predictive of retinopathy and nephropathy both in the intensively and the conventionally treated patients (all P≤0.001). However, the number of hypoglycaemic episodes did not add to HbA1c in predicting retinopathy [odds ratio (95%CI) 0.99 (0.96-1.01), P=0.51 in intensively treated patients, 0.94 (0.89-1.00), P=0.05, conventional] or nephropathy [odds ratio (95%CI) 0.98 (0.95-1.01), P=0.48 intensive, 1.03 (0.98-1.10), P=0.17 conventional]. Conclusions The frequency of exposure to severe hypoglycaemia did not predict a different risk of developing retinopathy or nephropathy in either treatment group of the Diabetes Control and Complications Trial at any given HbA1c.

KW - Glycated haemoglobin

KW - Hypoglycaemia

KW - Nephropathy

KW - Retinopathy

KW - Type1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84865145554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865145554&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2012.03612.x

DO - 10.1111/j.1464-5491.2012.03612.x

M3 - Article

C2 - 22332940

AN - SCOPUS:84865145554

VL - 29

SP - 1195

EP - 1198

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 9

ER -